Cardiomegaly medical therapy: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
{{CMG}}; '''Associate Editor in Chief:''' {{CZ}} | {{CMG}}; '''Associate Editor in Chief:''' {{CZ}} | ||
==Overview== | ==Overview== | ||
[[Diuretics]] and [[ACE inhibitor]]s are standard therapy for the chronic treatment of cardiomegaly. Acute therapies include [[ | [[Diuretics]] and [[ACE inhibitor]]s are standard therapy for the chronic treatment of cardiomegaly. Acute therapies include [[preload]] and [[afterload]] reduction. | ||
==Medical Therapy== | ==Medical Therapy== |
Latest revision as of 10:07, 9 August 2013
Cardiomegaly Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cardiomegaly medical therapy On the Web |
Directions to Hospitals Treating Cardiomegaly medical therapy |
Risk calculators and risk factors for Cardiomegaly medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor in Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Diuretics and ACE inhibitors are standard therapy for the chronic treatment of cardiomegaly. Acute therapies include preload and afterload reduction.
Medical Therapy
Acute Pharmacotherapies
Diuretics and nitrates are administered acutely to reduce preload and afterload.
Chronic Pharmacotherapies
A combination of diuretics and angiotensin converting enzyme (ACE) inhibition is currently the standard of care. Digoxin may reduce the frequency of rehospitalization, but does not improve mortality.